S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q4 2021

Avoro Capital Advisors

Period: Q4 2021 Β· Filed: 2022-02-14
View on SEC EDGAR β†—
AUM
$5.88B
Total portfolio value
Positions
41
Reported securities
Top Holding
HZNP
17.1% $1.00B
QoQ Changes
+3 / -7
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
HZNPHORIZON THERAPEUTICS PLC$1.00B17.05%β€”β€”
17.1%
MRTXMIRATI THERAPEUTICS INC$744.5M12.67%β€”β€”
12.7%
UTHRUNITED THERAPEUTICS CORP$655.8M11.16%$216.08$555.91+157.3%
11.2%
APLSAPELLIS PHARMACEUTICALS INC$404.5M6.88%$47.28β€”
6.9%
ARGXARGENX SE$337.9M5.75%$350.19$939.68+168.3%
5.8%
SRPTSAREPTA THERAPEUTICS INC$281.4M4.79%$90.05$19.28-78.6%
4.8%
ASNDASCENDIS PHARMA$269.1M4.58%$134.53$274.50+104.0%
4.6%
BMRNBIOMARIN PHARMACEUTICAL INC$247.4M4.21%$88.35$58.99-33.2%
4.2%
FOLDAMICUS THERAPEUTICS INC$213.7M3.64%β€”β€”
3.6%
ALNYALNYLAM PHARMACEUTICALS INC$182.3M3.10%$169.58$312.78+84.4%
3.1%
IOVAIOVANCE BIOTHERAPEUTICS INC$165.6M2.82%$19.09$4.31-77.4%
2.8%
XENEXENON PHARMACEUTICALS INC$155.7M2.65%$31.24$60.96+95.1%
2.6%
ISEEIVERIC BIO INC$121.2M2.06%β€”β€”
2.1%
MDGLMADRIGAL PHARMACEUTICALS INC$120.8M2.06%$84.74$528.10+523.2%
2.1%
XBISPDR SERIES TRUST - S&P BIOTECH$117.6M2.00%$111.25$160.46+44.2%
2.0%
ARNAARENA PHARMACEUTICALS INC$114.8M1.95%β€”β€”
1.9%
GLUEMONTE ROSA THERAPEUTICS INC$67.6M1.15%$20.42$24.21+18.6%
1.1%
KURAKURA ONCOLOGY INC$56.0M0.95%$14.00$11.10-20.7%
0.9%
ACADACADIA PHARMACEUTICALS INC$51.4M0.87%$23.34$25.97+11.3%
0.9%
SNDXSYNDAX PHARMACEUTICALS INC$47.6M0.81%$21.89$21.82-0.3%
0.8%
WHWKAADI BIOSCIENCES INC$44.2M0.75%$24.15$4.19-82.7%
0.8%
MRSNMERSANA THERAPEUTICS INC$42.3M0.72%β€”β€”
0.7%
MNKDMANNKIND CORP$38.5M0.65%$4.37$4.52+3.4%
0.7%
MRNSMARINUS PHARMACEUTICALS INC$38.4M0.65%β€”β€”
0.7%
PRAXPRAXIS PRECISION MEDICINES INC$35.1M0.60%$295.50$318.52+7.8%
0.6%
DSGNDESIGN THERAPEUTICS INC$35.0M0.60%$21.41$15.64-26.9%
0.6%
KYMRKYMERA THERAPEUTICS INC$34.9M0.59%$63.49$113.51+78.8%
0.6%
CBAYCYMABAY THERAPEUTICS INC$34.8M0.59%β€”β€”
0.6%
PMVPPMV PHARMACEUTICALS INC$33.8M0.58%$23.10$1.22-94.7%
0.6%
KRYSKRYSTAL BIOTECH INC$33.2M0.57%$69.95$375.07+436.2%
0.6%

Quarter-on-Quarter Activity

Q4 2021 vs. Q3 2021

New Positions (3)

TickerIssuerNotionalSince Filing
XBISPDR SERIES TRUST - S&P BIOTECH$117.6M+44.2%
KRYSKRYSTAL BIOTECH INC$33.2M+436.2%
IOBTQIO BIOTECH INC$10.2M

Exited Positions (7)

TickerIssuerNotional
XLRNACCELERON PHARMA INC$688.4M
VRTXVERTEX PHARMACEUTICALS INC$120.4M
TRILLIUM THERAPEUTICS INC$100.1M
DCPHDECIPHERA PHARMACEUTICALS INC$36.3M
BIIBBIOGEN INC$23.8M
MRUSMERUS N V$9.9M
XLRNACCELERON PHARMA INC$0.0M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
SRPTCALLSAREPTA THERAPEUTICS INC$279.2M+1462.5%-78.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$164.1M+1234.6%-77.4%
APLSAPELLIS PHARMACEUTICALS INC$403.3M+464.7%
APLSAPELLIS PHARMACEUTICALS INC$239.7M+71.1%
SRPTCALLSAREPTA THERAPEUTICS INC$0.7M+50.0%-78.6%
BMRNBIOMARIN PHARMACEUTICAL INC$102.5M+49.3%-33.2%
SNDXSYNDAX PHARMACEUTICALS INC$18.1M+40.8%-0.3%
XENEXENON PHARMACEUTICALS INC$100.0M+36.6%+95.1%

Trimmed (7)

TickerIssuerNotionalShares Ξ”Since Filing
SRPTCALLSAREPTA THERAPEUTICS INC$-228.3M-88.0%-78.6%
ARNAARENA PHARMACEUTICALS INC$-89.2M-63.9%
PMVPPMV PHARMACEUTICALS INC$-53.3M-49.9%-94.7%
DICEDICE THERAPEUTICS INC$-12.0M-29.7%
FENCFENNEC PHARMACEUTICALS INC$-10.4M-28.1%
AVDLXXXXAVADEL PHARMACEUTICALS PLC$-8.8M-26.6%
NUVLNUVALENT INC$-3.9M-12.3%
← Back to Hedge Funds